Integrated BioPharma, Inc.
Integrated BioPharma, Inc. (INBP) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001016504 · INBP · OTC · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001016504 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Integrated BioPharma, Inc. (OTC: INBP) has submitted 547 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1996. As a Consumer Defensive sector company with CIK 0001016504, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Integrated BioPharma, Inc.'s most comprehensive regulatory disclosure. The most recent Integrated BioPharma, Inc. 10-K was filed on 2025-09-23 for fiscal year ending 2025. Historical INBP 10-K annual reports are available from 1996 through 2025.
Investors researching Integrated BioPharma, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
INBP SEC Filings · 8 questionsIntegrated BioPharma, Inc. (INBP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 547 filings and access original documents at no cost. Integrated BioPharma, Inc.'s CIK is 0001016504.